Post-stroke hyperglycaemia – Treatment with Exenatide in Acute Ischaemic Stroke (TEXAIS) trial [ 2017 - 2019 ]

Research Grant

Researchers: Prof Christopher Bladin (Principal investigator) ,  A/Pr Elif Ekinci ,  Prof Helen Dewey ,  Prof Leonid Churilov ,  Prof Ngai Cheung
View all 6 related researchers

Brief description Raised blood glucose levels (hyperglycaemia) after a stroke is common. It reduces the efficacy of stroke treatments and results in worse outcomes. Insulin is not useful as a treatment for this as it causes frequent hypoglycaemia and does not improve clinical outcomes. Exenatide is a common diabetes drug that is simple to use and lowers blood glucose without hypoglycaemia. It will be tested in the Treatment with Exenatide in Acute Ischaemic Stroke (TEXAIS) trial.

Funding Amount $AUD 1,295,710.15

Funding Scheme Project Grants

Notes Standard Project Grant